These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29729119)

  • 21. Palliative care in heart failure.
    Wiskar K; Toma M; Rush B
    Trends Cardiovasc Med; 2018 Oct; 28(7):445-450. PubMed ID: 29735287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient and Caregiver Perspectives on Palliative Care in End-Stage Liver Disease.
    Donlan J; Ufere NN; Indriolo T; Jackson V; Chung RT; El-Jawahri A; Traeger L
    J Palliat Med; 2021 May; 24(5):719-724. PubMed ID: 32996824
    [No Abstract]   [Full Text] [Related]  

  • 23. Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.
    Hansen L; Lyons KS; Dieckmann NF; Chang MF; Hiatt S; Solanki E; Lee CS
    Res Nurs Health; 2017 Oct; 40(5):398-413. PubMed ID: 28666053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
    Walling AM; Ahluwalia SC; Wenger NS; Booth M; Roth CP; Lorenz K; Kanwal F; Dy S; Asch SM;
    Dig Dis Sci; 2017 Jan; 62(1):84-92. PubMed ID: 27804005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit.
    Olson JC; Karvellas CJ
    Liver Transpl; 2017 Nov; 23(11):1465-1476. PubMed ID: 28688155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative care for patients with end-stage liver disease.
    Larson AM
    Curr Gastroenterol Rep; 2015 May; 17(5):440. PubMed ID: 25855211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.
    Patel SS; Guzman LA; Lin FP; Pence T; Reichman T; John B; Celi FS; Liptrap E; Bhati C; Siddiqui MS
    Liver Transpl; 2018 Jul; 24(7):872-880. PubMed ID: 29624871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospice care for end stage liver disease in the United States.
    Orman ES; Johnson AW; Ghabril M; Sachs GA
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):797-809. PubMed ID: 33599185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of palliative care utilization among patients with end stage liver disease during end-of-life hospitalizations: A population-level analysis.
    Oud L
    J Crit Care; 2018 Dec; 48():290-295. PubMed ID: 30269008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Trends in Palliative Care Utilization in Patients With Decompensated Liver Disease: 2016-2020 National Analysis.
    Sohal A; Chaudhry H; Sharma R; Dhillon N; Kohli I; Singla P; Arora K; Dukovic D; Verma M; Roytman M
    J Palliat Med; 2024 Mar; 27(3):335-344. PubMed ID: 37851991
    [No Abstract]   [Full Text] [Related]  

  • 31. Palliative Care and Hospice Referrals in Patients with Decompensated Cirrhosis: What Factors Are Important?
    Holden JH; Shamseddeen H; Johnson AW; Byriel B; Subramoney K; Cheng YW; Saito A; Ghabril M; Chalasani N; Sachs GA; Orman ES
    J Palliat Med; 2020 Aug; 23(8):1066-1075. PubMed ID: 32091954
    [No Abstract]   [Full Text] [Related]  

  • 32. The Organ Transplant Imperative.
    Santivasi WL; Strand JJ; Mueller PS; Beckman TJ
    Mayo Clin Proc; 2017 Jun; 92(6):940-946. PubMed ID: 28499512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockers and physical frailty in patients with end-stage liver disease.
    Kuo SZ; Lizaola B; Hayssen H; Lai JC
    World J Gastroenterol; 2018 Sep; 24(33):3770-3775. PubMed ID: 30197482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of a rural palliative supportive service.
    Pesut B; Hooper BP; Robinson CA; Bottorff JL; Sawatzky R; Dalhuisen M
    Rural Remote Health; 2015; 15(2):3116. PubMed ID: 25939666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease.
    Derck JE; Thelen AE; Cron DC; Friedman JF; Gerebics AD; Englesbe MJ; Sonnenday CJ
    Transplantation; 2015 Feb; 99(2):340-4. PubMed ID: 25606782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
    Kim S; Lee K; Kim C; Choi J; Kim S
    Gastroenterol Nurs; 2022 Mar-Apr 01; 45(2):101-112. PubMed ID: 34269708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.
    Peng JK; Hepgul N; Higginson IJ; Gao W
    Palliat Med; 2019 Jan; 33(1):24-36. PubMed ID: 30345878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview of Cirrhosis in Children.
    Cordova J; Jericho H; Azzam RK
    Pediatr Ann; 2016 Dec; 45(12):e427-e432. PubMed ID: 27975111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of performance status, psychosocial interventions, and early palliative care on overall survival.
    Simone CB
    Ann Palliat Med; 2016 Apr; 5(2):E4-6. PubMed ID: 27121745
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: A Phase 0-I study.
    Scheerens C; Chambaere K; Pardon K; Derom E; Van Belle S; Joos G; Pype P; Deliens L
    PLoS One; 2018; 13(9):e0203326. PubMed ID: 30231042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.